HGTY.NYSEHagerty, INC

425: Hagerty Launches Warrant Exchange Offer and Consent Solicitation to Simplify Capital Structure

Sentiment:

Warrant Exchange Offer Announcement


Hagerty, Inc. has commenced an exchange offer and consent solicitation to allow warrant holders to exchange their warrants for Class A Common Stock, aiming to simplify the company's capital structure and reduce potential dilution.

Summary

  • Hagerty, Inc. has announced an exchange offer and consent solicitation related to its outstanding warrants.
  • The company is offering 0.20 shares of Class A Common Stock for each outstanding warrant tendered.
  • Concurrently, Hagerty is soliciting consents to amend warrant agreements, allowing the company to exchange remaining warrants after the offer for 0.18 shares each, a 10% reduction from the offer exchange ratio.
  • Parties holding approximately 44.3% of Public Warrants, 57.2% of Private Placement Warrants, and 81.5% of PIPE Warrants have agreed to tender their warrants and consent to the amendments.
  • The offer and consent solicitation will expire on July 2, 2024, at 11:59 p.m. Eastern Time, unless extended.
  • The company has filed a prospectus/offer to exchange and Schedule TO with the SEC.
  • If all warrant holders tender their warrants, Hagerty expects to issue up to 3,896,707 shares, increasing the outstanding Class A Common Stock by approximately 4.5% to 89,599,993 shares, and have no warrants outstanding.

Sentiment

Score: 7

Explanation: The announcement is generally positive as it aims to simplify the capital structure and reduce potential dilution. The fact that a significant portion of warrant holders have already agreed to tender their warrants and consent to the amendments is also a positive sign. However, the issuance of new shares will cause some dilution.

Positives

  • The exchange offer aims to simplify Hagerty's capital structure.
  • Reducing the number of outstanding warrants can decrease potential dilution for existing shareholders.
  • Significant warrant holders have already committed to the offer, increasing the likelihood of successful amendment of warrant agreements.

Negatives

  • The exchange offer will result in the issuance of new shares, potentially diluting existing shareholders' ownership, although the company states this will be approximately 4.5% if all warrants are tendered.
  • If the consent solicitation fails, the company may not be able to exchange the remaining warrants at the reduced ratio of 0.18 shares.

Risks

  • The company's ability to compete effectively and retain customers is a risk.
  • Maintaining strategic relationships with insurance partners is crucial.
  • Fraudulent activity and technology disruptions pose ongoing risks.
  • The cyclical nature of the insurance business and unexpected claims increases could impact performance.
  • Compliance with various laws and regulations is essential.
  • The company faces risks associated with being a controlled company.
  • Ongoing or future litigation, government inquiries, and investigations could pose risks.

Future Outlook

The company expects to simplify its capital structure and reduce potential dilution through the exchange offer and consent solicitation. The success of the offer depends on warrant holder participation and consent to the proposed amendments.

Industry Context

Companies often undertake warrant exchange offers to streamline their capital structure, reduce potential dilution, and improve investor perception. This move aligns with common corporate finance strategies to optimize the balance sheet.

Comparison to Industry Standards

  • Many companies with outstanding warrants from SPAC mergers have undertaken similar exchange offers to reduce potential dilution.
  • For example, companies like Skillz and Opendoor have executed warrant redemption or exchange programs.
  • The exchange ratio of 0.20 shares per warrant is within the typical range seen in similar transactions, although the subsequent reduction to 0.18 shares if the consent solicitation is successful adds a unique element.
  • The level of support already secured from warrant holders (44.3% of Public, 57.2% of Private Placement, and 81.5% of PIPE) is a positive indicator compared to some other companies that have struggled to achieve sufficient participation.

Stakeholder Impact

  • Shareholders may experience slight dilution if all warrants are exchanged.
  • Warrant holders have the opportunity to exchange their warrants for Class A Common Stock.
  • The company aims to create a simpler capital structure, which could benefit all stakeholders in the long term.

Next Steps

  • Warrant holders will need to decide whether to tender their warrants before the expiration date of July 2, 2024.
  • The company will need to secure additional consents from Public Warrant holders to meet the 50% threshold for the IPO Warrant Amendment.
  • The SEC will need to declare the registration statement on Form S-4 effective before the shares can be issued.

Key Dates

DateDescription
April 8, 2021Date of the IPO Warrant Agreement between the Company (as successor to Aldel Financial Inc. (Aldel)) and Continental Stock Transfer & Trust Company (CST), as warrant agent
December 2, 2021Date of the Business Combination Warrant Agreement between the Company (as successor to Aldel) and CST
May 15, 2024Date used to calculate the number of outstanding shares of Class A Common Stock, Series A Preferred Stock, Class V Common Stock, and Warrants.
June 3, 2024Date of the announcement and commencement of the exchange offer and consent solicitation.
July 2, 2024Expiration date of the exchange offer and consent solicitation (unless extended).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.